# OnCo record andrea-necchi (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/andrea-necchi/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "andrea-necchi" ;
  schema:name "Andrea Necchi"@en ;
  schema:description "Led PURE-01, the first neoadjuvant pembrolizumab trial in bladder cancer, and now leads bladder-preserving immunotherapy studies."@en ;
  schema:url <https://onco.cc/people/andrea-necchi/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Necchi%20A%5BAuthor%5D%20bladder%20pembrolizumab> ;
  onco:tag "urothelial", "neoadjuvant", "italy" ;
  schema:jobTitle "Head of Genitourinary Medical Oncology, IRCCS San Raffaele Hospital; Professor, Vita-Salute San Raffaele University" ;
  schema:sameAs <https://orcid.org/0000-0002-3007-2756> ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:institutions <https://onco.cc/institutions/san-raffaele/> ;
  onco:trials <https://onco.cc/trials/sunrise-1/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-sunrise-1-jco-2025/> ;
  onco:journals <https://onco.cc/journals/european-urology/> ;
  schema:affiliation <https://onco.cc/institutions/san-raffaele/> .